AIM: To summarize the phenotypes and identify the underlying genetic cause of the fibrillin-1 (FBN1) gene responsible for congenital ectopia lentis (EL) in two Chinese families in northern China.
INTRODUCTION
E ctopia lentis (EL; OMIM 129600) is characterized by a displacement or malposition of the optic lens from its normal location and the zonular filaments are stretched or discontinued [1] . Most EL cases are associated with Marfan syndrome (MFS; OMIM 154700), an autosomal dominant disease that includes cardiovascular, skeletal, and ocular system abnormalities [2] . The clinical manifestations of isolated EL are mild or severe. The main symptoms include refractive error, amblyopia, complex glaucoma or retinal detachment. EL seriously affects visual quality. It is the second most frequent cause of lens surgery in juveniles [3] . FBN1 is located on chromosome 15q21.1. Mutations in FBN1 can cause isolated or predominant EL [4] . Fibrillin 1 is a cysteine-rich glycoprotein that is broadly distributed in elastic and nonelastic connective tissues [5] [6] . Both syndromic and isolated EL have strong genetic heterogeneity. Pathogenic variants in FBN1 [7] can cause connective tissue disorders such as MFS and autosomal dominant EL. To date, the Universal Mutation Database (UMD)-FBN1 database (http://www.umd.be/FBN1/) have registered over 600 FBN1 mutations [8] . It is vital to isolate EL and its related diseases by genotype and phenotype correlations. The study of molecular genetics of FBN1 contributes to the development of prenatal diagnosis of this gene-related disease, and also contributes to the early diagnosis and risk prediction of high-risk patients. Isolated EL pedigree has been reported many times in different races [7] [8] [9] [10] . Isolated EL may be an independent subtype caused by specific FBN1 mutations or other regulatory factors. We recruited two Chinese pedigrees affected with isolated EL. Mutation in the FBN1 gene (c.1633C>T) was reported in different races [9] . The mutation (c.2420_IVS20-8delTCTGAAACA insCGAAAG) in FBN1 was first discovered in EL patients. We conducted clinical and molecular genetic assessments in two Chinese families. However, the correlation between phenotype and genotype is important for understanding the pathogenesis of the disease, and the relevance of the two needs to be further clarified.
SUBJECTS AND METHODS

Ethical Approval
The study was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from all the participants. Clinical Examination The two autosomal dominant EL families came from Qingdao (Shandong Province, China). All family members included in the study had received comprehensive medical history review, ophthalmic examination. Two hundred individuals in the control group were healthy. FAMILY-1 (four generations) had sixteen individuals (seven affected and nine unaffected, ten males and six females). There were thirty-two individuals in FAMILY-2 (five generations, ten affected and twenty-two unaffected, nineteen males and thirteen females). FAMILY-1 and FAMILY-2 family members do not have diseases of other systems other than the visual system. Targeted Next-generation Sequencing Whole blood genomic DNA extraction was performed with DNA extraction kit (Tiangen, Beijing, China) from venous blood. Inheritable genetic vision system-related genes were captured as described [10] . The probands (IV:2 in FAMILY-1, V:2 in FAMILY-2) underwent next-generation sequencing of the gene panel.
The biotinylated capture probes were used to enrich the exon regions of these 523 genes. Variant Analysis and Verification According to the reference genome, data were analyzed and provided as described [10] . After variant annotation, we primarily analyzed the nonsynonymous variants, coding indels, splice site variants. Exome data were filtered by the public databases (1000 Genomes Project, dbSNP, YH database, and HapMap 8 database). Sanger sequencing was used to sequence the mutation sites selected by the filtration. Haplotyping was used to confirm the mutation sequence as described [10] . Ribonucleic Acid Extraction and Real-time Polymerase Chain Reaction Real-time PCR was performed using SYBR Premix Ex Taq kit (Tiangen). FBN1 primer sequences were 5'-CGCAACGCCGAATGCATCAA-3' (forward) and 5'-TGCAGCGGCAGTTGAAGGAA-3' (reverse). Glyceraldehyde-3-phosphate dehydroge nase (GAPDH) was assessed as described [11] .
RESULTS
Clinical Findings
The two families in this study lived in northern China. FAMILY-1 was an autosomal dominant fourgeneration family with a total of 16 members, of which 6 were affected by bilateral congenital EL ( Figure 1A, Figure 2 ). The right eye of II:2 had bullous keratopathy (Figure 2 ). Cataract were present in the left eyes of II:2 and III:2 and the right eye of III:4 ( Figure 2 ). The onset age of patients with EL was around 8 to 15y. None of the affected members displayed cardiovascular or skeletal abnormalities, and other Marfanrelated syndromes. We identified another five-generation family with ten confirmed individuals affected with autosomal dominant EL ( Figure 1B) . Bilateral nasal dislocations were detected in the seven living patients (Figure 3 ). The onset age of patients with EL was around 6 to 17y. Associated Gene FBN1 A total of 523 inheritable genes were captured and sequenced by targeted next-generation sequencing in the two probands (IV:2 in FAMILY-1, V:2 in FAMILY-2). The reads were mapped and analyzed by BWA (Burrows-Wheeler Alignment). IV:2 in FAMILY-1 had a mean depth of 54.1% and 84.52% of the exome sequences were covered at 10× or more in the captured panel. V:2 in FAMILY-2 had a mean depth of 85.89% and 94.8% of the exome sequences were covered at 10× or more in the captured panel. There were 37 non-synonymous SNPs, 2 indels, and 4 splicing sites in IV:2 of FAMILY-1. There were 29 nonsynonymous SNPs and 8 indels in V:2 of FAMILY-2.
Verification of Candidate Gene FBN1 by Sanger
Sequencing Only a heterozygous mutation (c.2420-IVS20-8delTCTGAAACAinsCGAAAG) was detected in exon 21 of the six affected individuals in FAMILY-1 (Figure 4 ) by using Sanger sequencing. Only a heterozygous mutation (c.1633C>T) was detected in exon 14 of the seven affected individuals in FAMILY-2 ( Figure 5 ). The mutation resulted in the substitution of a arginine codon for a cysteine codon (p.Arg545Cys). c.2420-IVS20-8delTCTGAAACAinsCGAAAG and c.1633C>T mutations were not detected in the normal family members and the 200 control subjects from the same ethnic background. Thus, the heterozygous c.2420-IVS20-8delTCTGAAACAinsCGAAAG and c.1633C>T mutation in FBN1 were co-segregated with the dominant GL phenotype in their families.
FBN1 Gene Expression in Patients with EL in FAMILY-1
FBN1 mRNA expression was detected in EL patients and normal members in FAMILY-1. The level of FBN1 mRNA in EL patients is 52% of that of unaffected members in the family (P=0.01). 
DISCUSSION
It is suggested that lens ectopicity may not be an independent diagnosis, but may be a mild manifestation of a broad clinical symptom spectrum of MFS [12] [13] [14] . In some cases, ectopic lens may be one of the signs of some syndromes, so metabolic screening and DNA testing have developed into an effective diagnostic method for distinguishing isolated EL from syndromes [15] [16] . By using next generation sequencing (NGS), multiple genes can be analyzed simultaneously and with high precision. The cost of this targeted approach has been greatly reduced, and the advantages of rapid detection and analysis are currently being used in standard clinical diagnostics. Differential diagnosis of EL and syndromic EL has important clinical significance, including patient prognosis, monitoring and prevention of potentially life-threatening complications. Moreover, genetic diagnosis of EL is critical to determining the genetic pattern and risk of recurrence of family members. In addition, a clear genetic diagnosis can help patients to consider reproductive options, and help relatives to perform pre-symptomatic DNA testing. This study was performed in two EL families in northern China by using NGS. A novel insertion deletion mutation (c.2420_IVS20-8 delTCTGAAACAinsCGAAAG, a heterozygous mutation) in FBN1 gene in FAMILY-1 was reported in a Chinese family in this study. The insertion site found in FAMILY-1 is located in the cbEGF domain of FBN1 protein, leading to early termination of translation and possibly affecting the binding of calcium to cbEGF. The clinical significance of this mutation is currently unknown, and further pedigree analysis and functional studies are needed to verify whether it is a pathogenic mutation. However, according to previous reports, the mutation has a high probability of pathogenicity. In addition, no similar nucleotide changes were detected in normal individuals in the family and 200 normal Chinese controls. And the mutation was filtered by the FBN1 SNP database. Many FBN1 mutations have been reported in the Chinese population [17] , and the clinical phenotypes caused by various FBN1 mutations are different. The missense mutation c.1633C>T in the FBN1 gene has been reported in various ethnic backgrounds [9, 18] . In a MFS family, people with this mutation have three different cardinal phenotypes (aortic dissection, EL and unaffected) [19] . FBN1, located on chromosome15q21, encodes a fibrinogen protein with a molecular weight of approximately 350-kDa. Fibrin-1 encoded by FBN1 is the major structural element in the lens suspensory ligament. Fibrin-1 is involved in the formation of the lens suspensory ligament [20] , which is mainly secreted by non-pigment cells in the ciliary body. FBN1 mutations can cause type 1 fibrillinopathies and MFS. Type 1 fibrillinopathies include Marchesani syndrome (MASS), isolated EL, isolated skeletal features of MFS, and thoracic aortic aneurysms [21] . To date, over 600 mutations in FBN1 have been reported. In addition to neonatal MFS, no correlation has been identified between genotypes/phenotypes [22] . In addition, recent studies have shown that cysteine substitutions, rather than the location of amino acids in protein sequences, are closely related to isolated or predominant EL [23] . In conclusion, we found a novel insertion deletion mutation (c.2420-IVS20-8delTCTGAAACA insCGAAAG, a heterozygous mutation) in FBN1 gene in FAMILY-1 with congenital EL and a known point mutations (c.1633C>T). The results will provide a theoretical basis for expanding the spectrum of congenital EL and clarifying the relationship between EL genotype and phenotype.
